Telomerase resets the homeostatic telomere length and prevents telomere dysfunction in immortalized human cells. 2004

Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
Massey Cancer Center, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

UI MeSH Term Description Entries
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000952 Antigens, Polyomavirus Transforming Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle. Polyomavirus Large T Antigens,Polyomavirus Middle T Antigens,Polyomavirus Small T Antigens,Polyomavirus T Proteins,Polyomavirus Transforming Antigens,Polyomavirus Tumor Antigens,SV40 T Antigens,SV40 T Proteins,Simian Sarcoma Virus Proteins,Polyomaviruses Large T Proteins,Polyomaviruses Middle T Proteins,Polyomaviruses Small T Proteins,Antigens, Polyomavirus Tumor,Antigens, SV40 T,Proteins, Polyomavirus T,Proteins, SV40 T,T Antigens, SV40,T Proteins, Polyomavirus,T Proteins, SV40,Transforming Antigens, Polyomavirus,Tumor Antigens, Polyomavirus
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D019098 Telomerase An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. Telomerase Catalytic Subunit,Telomerase Reverse Transcriptase,Telomerase Reverse Transcriptase Catalytic Subunit,Catalytic Subunit, Telomerase,Reverse Transcriptase, Telomerase,Subunit, Telomerase Catalytic,Transcriptase, Telomerase Reverse
D035341 Telomeric Repeat Binding Protein 2 A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the cell cycle. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 1 in that it contains basic N-terminal amino acid residues. TRF2 Protein,TERF2 Protein,TRBF2 Protein,Trf2 Gene Product,Gene Products, Trf2,Products, Trf2 Gene,Proteins, TERF2,Proteins, TRBF2,Proteins, TRF2,TERF2 Proteins,TRBF2 Proteins,TRF2 Proteins,Trf2 Gene Products

Related Publications

Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
June 2008, Oncology reports,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
January 2009, Nucleic acids symposium series (2004),
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
January 1996, Molecular and cellular biology,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
February 2015, Biology of reproduction,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
November 1998, European journal of cancer (Oxford, England : 1990),
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
October 1997, Biochemical and biophysical research communications,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
February 2012, Toxicology and applied pharmacology,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
April 2003, Mechanisms of ageing and development,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
October 2005, Proceedings of the National Academy of Sciences of the United States of America,
Patricia A McChesney, and Kristi C Turner, and Colleen Jackson-Cook, and Lynne W Elmore, and Shawn E Holt
June 2009, Toxicology,
Copied contents to your clipboard!